In a groundbreaking development that could change the lives of thousands of people with spinal cord injuries, European researchers have discovered that a specialized antibody treatment may help ...
NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback